Vallexa Advisors card: Physician Fee Schedule 2027, what the cut does to your billing company, proposed conversion factor $32.84, down 1.68%

Physician Fee Schedule 2027: What the Medicare Cut Does to Your Medical Billing Company’s Value

If you own a medical billing or revenue cycle management (RCM) company, the 2027 Medicare Physician Fee Schedule is a revenue event for you even though you never see a patient. Most billing companies are paid on what their clients collect. When Medicare pays physicians less per service, your clients collect less, and a percentage-of-collections fee shrinks with them. A buyer reviewing your company this winter will run that math before making an offer.

This guide explains what CMS proposed for 2027, which parts of the rule reach a billing company’s revenue line, how buyers turn a fee schedule change into a price, and what to prepare before the final rule lands. Every number below comes from a primary source, named and linked where it appears.

What CMS proposed for the 2027 Physician Fee Schedule

On July 14, 2026, CMS issued the calendar year 2027 Physician Fee Schedule (PFS) proposed rule. It was published in the Federal Register on July 16 as document 2026-14327, and the comment period closed on September 14, 2026. The changes apply to services furnished on or after January 1, 2027. The final rule is expected in early November.

The headline is the conversion factor, the dollar amount that turns relative value units into a payment. According to the CMS fact sheet on the proposed rule, there are now two conversion factors, and both fall:

Conversion factor2026 (current)2027 (proposed)Change
Qualifying APM participants (QPs)$33.57$33.17minus $0.40 (-1.19%)
Everyone else (non-QPs)$33.40$32.84minus $0.56 (-1.68%)

Source: CMS fact sheet, CY 2027 PFS proposed rule, July 14, 2026.

A QP is a clinician who meets participation thresholds in an Advanced Alternative Payment Model. Unless a client clears those thresholds, the non-QP factor applies, so for most independent practice books the number to plan around is the 1.68% cut. Check each large client’s QP status rather than assuming.

Why the 2027 cut happens: the 2.5% bump expires

The cut is not a new policy choice so much as a temporary raise running out. The CMS fact sheet explains that Public Law 119-21 gave the PFS a one-year conversion factor increase of 2.50% for 2026 only. That increase is not in effect for 2027, which CMS says “effectively means” current law requires a 2.50% reduction compared to 2026.

Three smaller pieces partly offset it, per the same fact sheet:

  • A statutory update of +0.75% for the QP conversion factor and +0.25% for the non-QP conversion factor.
  • An estimated +0.53% adjustment tied to proposed changes in work RVUs for some services.
  • The net result is the 1.19% and 1.68% declines in the table above.

Two points matter for a seller. First, the cut lands on January 1 whether or not Congress acts later. Congress has stepped in on physician pay before, but a buyer will not pay you today for a fix that has not passed. Second, the averages hide wide swings by specialty. In the proposed rule, CMS publishes a specialty impact table (Table D-B5, “CY 2027 PFS Estimated Impact on Total Allowed Charges by Specialty”), and the rule itself warns that actual revenue effects will differ with each practitioner’s volume and mix of services. Your client list is a specific mix of specialties, so your exposure is specific too.

How a fee schedule cut reaches a billing company’s revenue

A billing company does not bill Medicare for itself, so it is easy to treat the PFS as somebody else’s problem. Buyers do not. Here is the chain they trace.

Percentage-of-collections contracts move with client payments

If your contracts pay you a percentage of collections, your revenue is a share of your clients’ revenue. A drop in what Medicare pays per service reduces collections on the Medicare portion of each client’s book, and your fee on that portion falls in step.

A simple illustration (hypothetical figures, not data): suppose your clients collect $30 million a year in total, 35% of it from services paid under the PFS, and you charge 6% of collections. A 1.68% cut on that Medicare portion reduces client collections by about $176,000, and your revenue by about $10,600. On its own, that is small. The reason buyers care is what happens to margin and to the clients themselves, covered below.

Commercial contracts pegged to Medicare can carry the cut further

Many commercial payer contracts with physician practices are written as a percentage of the Medicare fee schedule. Where a client’s contract works that way, a lower Medicare conversion factor can pull commercial payments down as well, depending on the contract’s terms and the year it references. A buyer will ask whether you know which of your larger clients have contracts like that. If you do, you can show the real exposure. If you do not, the buyer will assume the worst case.

Your cost base does not shrink with the fee schedule

The cost side of a billing company is mostly people. The Bureau of Labor Statistics reports 194,720 medical records specialists employed nationally in May 2025, with a median annual wage of $51,140 and a mean of $56,790 (BLS OEWS, SOC 29-2072). Coders, billers and denial specialists do not take a pay cut when Medicare does. When revenue per claim falls and labor cost per claim stays flat or rises, margin compresses. That is the line a buyer is really underwriting.

Practice stress turns into client churn and pricing pressure

Independent practices feel a fee schedule cut directly. Some respond by renegotiating vendor fees, some consolidate into health systems or larger groups that bring billing in house, and some move to a cheaper vendor. Each of those is a risk to your recurring revenue. A buyer will look for evidence that your clients stayed through earlier rate cycles and that your fee level held.

Three other 2027 PFS proposals that touch billing companies

The conversion factor gets the attention, but three other proposals in the same rule can matter more for specific billing companies.

Remote patient monitoring billed through contracted staff

This one can hit RCM companies that also run remote monitoring programs for clients. CMS proposes to pay for remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) only when the services are furnished by clinical staff employed by the practice. In the rule’s words, if finalized, beginning January 1, 2027, the RPM and RTM codes “will not allow contracting out to third-party companies” (Federal Register 2026-14327). CMS cites an HHS Office of Inspector General report on remote monitoring oversight as part of its reasoning. The CMS fact sheet adds two more proposed requirements: a separately reportable initiating visit at the start of RPM or RTM, and RTM limited to established patients.

If part of your revenue comes from supplying nurses or care coordinators who perform monitoring time that your clients then bill, a buyer will treat that revenue as at risk until the final rule settles it. Separate it in your financials now so it does not cloud the rest of the business.

Lab clients and the Clinical Laboratory Fee Schedule

If you bill for clinical laboratories, a different schedule applies. The CMS fact sheet says that beginning in 2027, payment reductions from moving the Clinical Laboratory Fee Schedule to private payer rate data would be subject to a phase-in of up to 15% per year through 2029. For a billing company with a concentrated lab book, a buyer will model several years of possible reductions on those clients, not one.

The E/M complexity add-on becomes a modifier

CMS also proposes to turn the visit complexity add-on code, HCPCS G2211, into a modifier that raises the associated office visit payment by 16% instead of paying a flat amount. For primary care heavy books this may partly cushion the conversion factor cut. It also means coding workflows, edits and payer rules change on January 1, which is exactly the kind of transition where a billing company shows its value or shows its gaps.

How buyers price PFS exposure when you sell

Buyers of billing and RCM companies, whether private equity backed platforms or strategic acquirers, value the business on earnings (adjusted EBITDA for larger companies, seller’s discretionary earnings for owner-operated ones) times a multiple. The 2027 fee schedule touches both parts of that equation.

Earnings. A buyer will rebuild your next twelve months of revenue with the 2027 rates in it. If your trailing twelve months reflect 2026 rates with the temporary 2.5% bump, the buyer will not treat that as the run rate. Expect a pro forma adjustment for the Medicare portion of each client’s collections, and for any pegged commercial contracts you can identify.

Multiple. The multiple reflects how durable and predictable your revenue is. Three things move it in a fee schedule year:

  1. Payer mix of the client book. A billing company whose clients depend heavily on Medicare PFS payments carries more rate risk than one serving practices with mostly commercial or self-pay revenue.
  2. Specialty concentration. If a large share of your revenue comes from one or two specialties, the specialty impact table matters more than the average. A book that is diversified across specialties is easier to underwrite.
  3. Pricing model. Flat-fee and per-claim contracts insulate you from rate cuts. Percentage-of-collections contracts tie you to them, though they also capture rate increases. Neither is wrong, but a buyer wants to see the mix clearly.

Client concentration already sets much of the price for billing companies, as we covered in why client concentration decides your price. A fee schedule cut makes that worse when your largest client is a Medicare-heavy practice.

Timing also matters. A company that goes to market in November or December will be priced with the final rule in hand. A company that goes to market in the spring will be priced on actual 2027 collections, which removes guesswork in both directions. If your clients’ 2027 collections hold up better than the headline cut suggests, waiting a quarter can help you. If they do not, waiting gives a buyer the proof.

What a buyer will ask for in diligence

Billing companies that have these items ready get faster, cleaner diligence and fewer price adjustments late in the process:

  • Revenue by client for the last 36 months, with each client’s specialty and approximate Medicare share of collections.
  • Contract terms by client: pricing model (percentage of collections, per claim, flat fee), term, renewal date and termination notice.
  • A list of clients whose commercial contracts you know are pegged to the Medicare fee schedule.
  • A 2027 pro forma that applies the proposed (and, once released, final) conversion factor to the Medicare portion of each client’s book.
  • Revenue from remote monitoring services, separated from core billing, with the staffing model behind it.
  • Lab client revenue, separated, with a view of possible Clinical Laboratory Fee Schedule reductions through 2029.
  • Client retention through earlier rate changes, including any clients lost to health system acquisitions.
  • Staffing cost per client or per claim, so a buyer can see your margin under the new rates.

For a broader checklist on getting a company ready for sale, see the Vallexa Prepare for Your Exit guide in our Seller Learning Center.

Five things to do before the final rule

  1. Run your 2027 exposure now. Use the proposed non-QP conversion factor ($32.84, down 1.68%) against the Medicare portion of each client’s collections. Then rerun it when the final rule is released.
  2. Read the specialty impact table for your top clients. The averages are not your number. Match your largest clients’ specialties against Table D-B5 in the final rule.
  3. Separate remote monitoring revenue. If any of it depends on contracted clinical staff, show it as its own line and describe what changes if the employed-staff proposal is finalized.
  4. Review your contract mix. If most of your revenue is percentage-of-collections, consider whether some clients would accept a minimum monthly fee or a hybrid structure at renewal. Do it as part of normal renewals, not as an emergency.
  5. Document how you handled the last transition. Buyers want to see that your team adjusted edits, workflows and client reporting quickly when codes and rules changed. G2211 becoming a modifier on January 1 is your next chance to prove it.

How this connects to the rest of your exit plan

Rate changes are one input. Others include artificial intelligence and prior authorization rules, covered in our guide to selling a medical billing or RCM company in 2026, and newer revenue lines such as No Surprises Act dispute work, covered in how buyers value IDR revenue. Our RCM and medical billing company valuation page explains how Vallexa approaches valuation for this vertical.

Many billing companies serve behavioral health practices, and buyers of those practices study the same payer questions. Two current Vallexa listings show how those businesses are presented to buyers: the Pediatric ABA Practice For Sale in Colorado and the IOP Outpatient License For Sale in California.

Frequently asked questions

What is the 2027 Medicare Physician Fee Schedule conversion factor?

In the CY 2027 proposed rule issued July 14, 2026, CMS proposed a conversion factor of $32.84 for clinicians who are not qualifying APM participants, down 1.68% from $33.40, and $33.17 for qualifying APM participants, down 1.19% from $33.57. The final rule is expected in early November and applies to services on or after January 1, 2027.

Why is the Physician Fee Schedule going down in 2027?

Public Law 119-21 gave the fee schedule a one-year 2.50% conversion factor increase for 2026 only. CMS says that increase is not in effect for 2027, so current law effectively requires a 2.50% reduction. Statutory updates of 0.75% or 0.25% and an estimated 0.53% adjustment partly offset it.

How does a Physician Fee Schedule cut affect a medical billing company?

Most billing companies are paid a percentage of what their clients collect. A lower Medicare conversion factor reduces client collections on Medicare services, so the billing fee on that portion falls too. Commercial contracts pegged to the Medicare fee schedule can extend the effect, while labor costs stay the same, which compresses margin.

Will the 2027 rule affect billing companies that offer remote patient monitoring?

It could. CMS proposed paying for remote physiologic and remote therapeutic monitoring only when the services are furnished by clinical staff employed by the billing practice. If finalized, beginning January 1, 2027, those codes could not be billed for services contracted out to third-party companies.

Should I sell my billing company before or after the final 2027 fee schedule?

It depends on your client mix. A buyer in November or December will price your company with the final rule in hand and will adjust trailing revenue for the expired 2.5% increase. Waiting for actual 2027 collections removes guesswork, which helps if your clients hold up better than the average and hurts if they do not. Running your exposure by client is the first step.

Talk to Vallexa about your billing company

Vallexa Advisors works with owners of medical billing and RCM companies who are one to three years from a sale. We work on a success fee basis and keep every engagement confidential. If you want to know how the 2027 fee schedule changes what your company is worth, contact Vallexa for a confidential conversation.

About the author. Jason A. Atty is Managing Director of Vallexa Advisors, a sell-side healthcare M&A advisory firm. He works with owners of home health, hospice, home care and other healthcare services businesses on valuation, buyer selection and sale structure. LinkedIn.

How we source our numbers. Every statistic in this article is checked at its primary source (CMS, the Federal Register, eCFR, BLS) before publication, and the sources are linked inline. Our standing Home Health and Hospice Market Data page carries the figures we compute ourselves from CMS files, with the date each was last refreshed.